INOV Inovalon Holdings Inc. Class A

Inovalon ONE® Platform Selected by Walmart

Inovalon ONE® Platform Selected by Walmart

Retailer’s Specialty Pharmacy Business to Implement ScriptMed® Cloud Solution to Empower Enhanced Outcomes and Economics for its Customers

BOWIE, Md., July 23, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a long-term engagement with Walmart’s Specialty Pharmacy business (NYSE: WMT) to provide cloud-based capabilities through the Inovalon ONE® Platform as part of its data-driven strategy to improve outcomes and economics for its customers.

The high-complexity and high-cost nature of specialty pharmacy stands to benefit significantly from the capabilities enabled through the Inovalon ONE® Platform. Through the implementation of ScriptMed® Cloud, a software-as-a-service (SaaS) cloud offering configured to address the unique needs of specialty pharmacy demands, the Inovalon ONE® Platform’s connectivity, supplemental clinical data, and process-specific analytics automate otherwise labor-intensive processes, pre-populate relevant clinical data, seamlessly apply appropriate care protocol analytics, and streamline operational process flows – ultimately enabling improvements in quality of care and operating expense efficiency at scale.

The Inovalon ONE® Platform will facilitate coordination of specialty medication dispensing from Walmart’s Specialty Pharmacy and available across Walmart’s extensive network of thousands of retail pharmacies, enabling Walmart in helping its customers achieve their best health, decrease prescription time-to-fill, lower costs-to-fill, and enhance key operational flexibilities and strategic insights key to very-large-scale operations.

“Our specialty pharmacy mission is to provide a flexible, dual-channel, patient-centric model that fosters positive clinical outcomes, great customer experiences, and everyday low price. Our patient approach is personalized and caring – designed to empower and inspire patients to choose healthy behaviors and live better,” said Mike Adloo, Specialty Lead health and wellness, Walmart.  “Inovalon’s capabilities in the specialty pharmacy market will play an integral role in support of our mission – delivering the best possible quality outcomes and experience for our patients while lowering their costs.”  

“Specialty pharmacy is a uniquely high-value segment of the healthcare ecosystem that is of increasing importance to payers, pharmaceutical companies and patients alike. The unique combination of our platform’s capabilities is highly differentiated within the marketplace, and a true thrill to bring to bear for such an industry leader as Walmart,” said Keith Dunleavy, M.D., chief executive officer of Inovalon. “Their clear focus on the customer, their experience, their outcomes, and their costs is remarkable.”

About ScriptMed® Cloud

ScriptMed® Cloud is the next generation technology for specialty patient care, empowered by the latest and most advanced capabilities of the Inovalon ONE® Platform. These advancements include increased modularity, high-speed cloud-based compute, multi-stakeholder workflows, real-time healthcare ecosystem connectivity, advanced analytics and enhanced data visualization capabilities, and leverage Inovalon’s massive datasets. ScriptMed® Cloud delivers differentiated value in the specialty market, meaningfully reducing time-to-fill, reducing costs and error rates, while empowering advanced functionality, greater flexibility, operational efficiency, and a focus on clinical and quality outcomes, delivering impactful savings and financial benefits for the specialty pharmacy marketplace and the patients who are served. ScriptMed® Cloud is a cloud native architecture provided to clients in a pure software-as-a-service (SaaS) offering model.

About the Inovalon ONE® Platform

The Inovalon ONE® Platform is an integrated cloud-based platform of nearly 100 individual proprietary technology toolsets and deep data assets able to be rapidly configured to empower the operationalization of large-scale, data-driven healthcare initiatives. Each proprietary technology toolset, referred to as a Module, is informed by the data of billions of medical events within Inovalon’s proprietary datasets. Combinations of Modules are configured to empower highly differentiated solutions for client needs quickly and in a highly scalable fashion. The flexibility of the Platform’s modular design enables clients to integrate the Platform capabilities with their own internal capabilities or other third-party solutions. The Platform brings to the marketplace a highly extensible, national-scale capability to interconnect with the healthcare ecosystem on a massive scale, aggregate and analyze data in petabyte volumes, arrive at sophisticated insights in real time, and drive meaningful impact wherever it is analytically identified best to intervene and intuitively visualize data and information to inform business strategy and execution.

About Inovalon

Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including 24 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than 994,000 physicians, 558,000 clinical facilities, 315 million Americans, and 55 billion medical events. For more information, visit .

Contact:

Kim E. Collins

Senior Vice President, Corporate Communications



301-809-4000 x1473

Hulus Alpay

Vice President, Investor Relations



301-809-4000 x1237

EN
23/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inovalon Holdings Inc. Class A

 PRESS RELEASE

Equity Consortium Led by Nordic Capital and Including Insight Partners...

Equity Consortium Led by Nordic Capital and Including Insight Partners Completes Acquisition of Inovalon Partnership to Advance Inovalon’s Mission of Empowering Data-Driven Healthcare BOWIE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the completion of its acquisition by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and chief executive officer Keith Dunleavy, M.D. and certain Class B stockholders o...

 PRESS RELEASE

Pharmacy Leaders and Technology Innovators Convene Virtually November ...

Pharmacy Leaders and Technology Innovators Convene Virtually November 8-9, 2021 Industry Experts Highlight Strategies for Advancing Data Sharing and Improving Pharmaceutical Patient Care at Inovalon’s ScriptMed® Conference BOWIE, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed® Conference will take place virtually from November 8-9, 2021. This prestigious two-day event features the industry’s leading executives and thought leaders discussing the ways in which techno...

 PRESS RELEASE

Inovalon to Host Virtual Client Congress October 18-19, 2021

Inovalon to Host Virtual Client Congress October 18-19, 2021 Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes on Data-Driven Healthcare BOWIE, Md., Oct. 13, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual Client Congress will take place virtually from October 18-19, 2021. Client Congress builds on a decade of bringing together the nation’s most influential voices to address the programs, perspectives, an...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2021 08 31

CTSH has built an industry-leading asset-based consulting business over the past 15 years, seeing remarkably stable returns and steady investment in growth, through various economic cycles and potentially impactful regulatory changes. However, the market is expecting both their ability to drive growth and sustain and improve profitability to severely erode going forward, with UAFRS-based (Uniform) ROA falling by half and growth slowing too. While markets are overly pessimistic, management is al...

Valens Research
  • Valens Research

INOV - Embedded Expectations Analysis - 2021 08 30

Inovalon Holdings, Inc. (INOV:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 37.0x Uniform P/E, implying somewhat bullish expectations for the firm. However, although management's concerns about revenue guidance, contract wins, and sales trend disruptions suggest potential short-term headwinds, market expectations are still too pessimistic, and longer-term equity outperformance remains warranted. Specifically, management may lack confidence in ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch